関連ニュース

Healthpeak gets its prior buy from Oct. 2025 reaffirmed. Positives include a supportive macro environment, dividend coverage and high yield, an investment-grade rating, and leasing growth in Q2. Selec

Healthpeak Properties remains a Buy, supported by strong earnings, attractive dividend, and an ongoing portfolio pivot despite macro headwinds. DOC delivered a robust Q2, beating FFO and revenue estim

Why sit around and wait all quarter long for a dividend payment where there are monthly dividend stocks available?